Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral sirolimus versus oral cyclosporine for chronic idiopathic thrombocytopenic purpura in children
IRCT20180501039499N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Oct 2018
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in immune thrombocytopenia (ITP) comparing Cyclosporine arm with Sirolimus arm (2 arms). Primary endpoint: Increase platelet count. Started Oct 2018; status: completed.
02
Drugs
sirolimuscyclosporine
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on IRCT20180501039499N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180501039499N1.